Results 241 to 250 of about 19,005,321 (291)

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Intravenous Immunoglobulin Resistant Incomplete Kawasaki Disease in a 4-Month-Old Infant: A Case Report. [PDF]

open access: yesClin Case Rep
Yadav S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy